|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
|
IE56702B1
(en)
*
|
1982-12-01 |
1991-11-06 |
Usv Pharma Corp |
Antiinflammatory antiallergic compounds
|
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
|
US5021456A
(en)
|
1988-02-25 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
|
US5563143A
(en)
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US7125880B1
(en)
|
1995-06-06 |
2006-10-24 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US6632823B1
(en)
|
1997-12-22 |
2003-10-14 |
Merck & Co., Inc. |
Substituted pyridine compounds useful as modulators of acetylcholine receptors
|
|
HRP20020599A2
(en)
|
2000-01-18 |
2004-08-31 |
Pfizer Prod Inc |
Corticotropin releasing factor antagonists
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US7102009B2
(en)
|
2001-01-12 |
2006-09-05 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US20030134836A1
(en)
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
US20020147198A1
(en)
|
2001-01-12 |
2002-10-10 |
Guoqing Chen |
Substituted arylamine derivatives and methods of use
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US7307088B2
(en)
|
2002-07-09 |
2007-12-11 |
Amgen Inc. |
Substituted anthranilic amide derivatives and methods of use
|
|
FI20030030A0
(fi)
|
2003-01-09 |
2003-01-09 |
Orion Corp |
Uusia yhdisteitä
|
|
CN1791592B
(zh)
|
2003-05-19 |
2012-07-04 |
Irm责任有限公司 |
免疫抑制剂化合物和组合物
|
|
WO2007016784A1
(en)
|
2005-08-11 |
2007-02-15 |
Merck Frosst Canada Ltd. |
Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors
|
|
JP2007519705A
(ja)
|
2004-01-29 |
2007-07-19 |
ファイザー・プロダクツ・インク |
Ｃｎｓ障害を治療するための非定型抗精神病薬とアミノメチルピリジルオキシメチル／ベンゾイソオキサゾールアザビシクロ誘導体の組合せ
|
|
DE602005022572D1
(de)
|
2004-03-12 |
2010-09-09 |
Lilly Co Eli |
Antagonisten des opioidrezeptors
|
|
EP1735268B1
(en)
|
2004-03-15 |
2012-02-15 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
BRPI0510305A
(pt)
|
2004-04-30 |
2007-10-02 |
Takeda Pharmaceutical |
composto ou um sal do mesmo, pródroga ou um sal da mesma, agente farmacêutico, método de produção do composto ou um sal do mesmo, inibidor de metaloproteinase de matriz ou um sal do mesmo ou uma pródroga do mesmo, método de inibir uma metaloproteinase de matriz, e, uso de um composto ou de um sal do mesmo ou de uma pródroga do mesmo
|
|
US7507748B2
(en)
|
2004-07-22 |
2009-03-24 |
Amgen Inc. |
Substituted aryl-amine derivatives and methods of use
|
|
BRPI0515143A
(pt)
|
2004-09-10 |
2008-07-08 |
Pfizer Prod Inc |
usos de derivados azabicìclicos de piridiloximetila e benzisoxazol para a preparação de uma composição farmacêutica para o tratamento dos distúrbios de humor
|
|
WO2006027692A2
(en)
|
2004-09-10 |
2006-03-16 |
Pfizer Products Inc. |
Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
|
|
US20080004269A1
(en)
|
2004-11-04 |
2008-01-03 |
Yuelian Xu |
Pyrazolylmethy Heteroaryl Derivatives
|
|
DE102004056226A1
(de)
|
2004-11-22 |
2006-05-24 |
Burchardt, Elmar Reinhold, Dr.Dr. |
Neuartige Inhibitoren der Lysyloxidase
|
|
CA2593858A1
(en)
|
2005-01-31 |
2006-08-10 |
Min Ge |
Antidiabetic bicyclic compounds
|
|
AR055041A1
(es)
|
2005-03-23 |
2007-08-01 |
Merck Frosst Canada Ltd |
Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas.
|
|
US7405302B2
(en)
|
2005-10-11 |
2008-07-29 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
ITMI20051943A1
(it)
*
|
2005-10-14 |
2007-04-15 |
Procos Spa |
Processo di risoluzione anantiomerica di 2-aminometil-pirrolidine 1-sostitute per ammidazione in presenza di lipasi
|
|
US20070219206A1
(en)
|
2005-11-04 |
2007-09-20 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (flap) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
US20070225285A1
(en)
|
2005-11-04 |
2007-09-27 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (flap) inhibitors
|
|
JP2009523820A
(ja)
|
2006-01-23 |
2009-06-25 |
アミラ ファーマシューティカルス，インコーポレーテッド |
５−リポキシゲナーゼの三環系抑制剤
|
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
|
WO2008020799A1
(en)
|
2006-08-18 |
2008-02-21 |
Astrazeneca Ab |
Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists
|
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
|
CA2693310C
(en)
|
2007-08-02 |
2018-11-27 |
Arresto Biosciences, Inc. |
Lox and loxl2 inhibitors, antibodies and uses thereof
|
|
WO2011017125A1
(en)
|
2009-07-28 |
2011-02-10 |
Anacor Pharmaceuticals, Inc. |
Trisubstituted boron-containing molecules
|
|
CN102711821A
(zh)
|
2009-08-21 |
2012-10-03 |
吉联亚生物科技有限公司 |
治疗方法和组合物
|
|
US8680246B2
(en)
|
2010-02-04 |
2014-03-25 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
|
|
CN103002742B
(zh)
|
2010-03-05 |
2016-07-13 |
卡尔约药物治疗公司 |
核转运调节剂及其应用
|
|
CA2818542A1
(en)
*
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
RU2014120166A
(ru)
|
2011-10-20 |
2015-11-27 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина
|
|
IN2014MN01982A
(https=)
|
2012-04-25 |
2015-07-10 |
Raqualia Pharma Inc |
|
|
EP3348576A1
(en)
|
2012-10-30 |
2018-07-18 |
Gilead Sciences, Inc. |
Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
|
|
CN104854086B
(zh)
|
2012-12-18 |
2017-06-27 |
Ea制药株式会社 |
杂环酰胺衍生物和含有其的药物
|
|
EP3129027A4
(en)
|
2014-02-14 |
2017-06-21 |
University of British Columbia |
Modulators of caspase-6
|
|
US9051320B1
(en)
|
2014-08-18 |
2015-06-09 |
Pharmakea, Inc. |
Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
|
|
SG11201706451TA
(en)
|
2015-02-15 |
2017-09-28 |
Hoffmann La Roche |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
|
|
JP6697809B2
(ja)
*
|
2015-03-06 |
2020-05-27 |
ファーマケア，インク． |
フッ素化リシルオキシダーゼ様２阻害剤とその使用
|
|
WO2016144702A1
(en)
|
2015-03-06 |
2016-09-15 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
|
KR102615565B1
(ko)
|
2016-09-07 |
2023-12-18 |
파마케아, 인크. |
리실 옥시다제 유사 2 억제제의 용도
|
|
KR102587178B1
(ko)
|
2016-09-07 |
2023-10-06 |
파마케아, 인크. |
리실 옥시다아제-유사 2 억제제의 결정질 형태 및 제조 방법
|